MX2021003668A - Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. - Google Patents
Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar.Info
- Publication number
- MX2021003668A MX2021003668A MX2021003668A MX2021003668A MX2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A MX 2021003668 A MX2021003668 A MX 2021003668A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- depression
- sequences
- administration
- days
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición farmacéutica inhalable que comprende ketamina o su sal farmacéuticamente aceptable para su uso en un método de tratamiento de la depresión mediante la administración por vía pulmonar, el tratamiento comprende un ciclo de múltiples secuencias de administración por inhalación, dicho ciclo dura de 10 a 30 días, en donde cada una de las múltiples secuencias de administración se realiza en un solo día, con intervalos de 2 a 4 días entre las secuencias, y cada una de dichas secuencias consiste en múltiples inhalaciones de dosis única separadas por un período de descanso que dura por lo menos 5 minutos; la composición es especialmente útil para el tratamiento de la depresión resistente al tratamiento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18461615.9A EP3628313A1 (en) | 2018-09-28 | 2018-09-28 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
| PCT/EP2019/075735 WO2020064748A1 (en) | 2018-09-28 | 2019-09-24 | Ketamine composition for use in a method of treatment of depression by pulmonary administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021003668A true MX2021003668A (es) | 2021-08-19 |
Family
ID=63713806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021003668A MX2021003668A (es) | 2018-09-28 | 2019-09-24 | Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11925607B2 (es) |
| EP (2) | EP3628313A1 (es) |
| JP (1) | JP7444864B2 (es) |
| KR (1) | KR20210068465A (es) |
| CN (1) | CN113038941A (es) |
| AU (1) | AU2019349624A1 (es) |
| BR (1) | BR112021005687A2 (es) |
| CA (1) | CA3114325A1 (es) |
| EA (1) | EA202190724A1 (es) |
| MX (1) | MX2021003668A (es) |
| WO (1) | WO2020064748A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3505157T (pt) * | 2017-12-29 | 2022-02-18 | Celon Pharma Sa | Composição de cetamina em pó seco para administração pulmonar em depressão resistente ao tratamento |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009469D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
| GB0523031D0 (en) * | 2005-11-11 | 2005-12-21 | Yaupon Therapeutics | Enhancement of morphine analgesia by s(-)-norketamine |
| JP2009530385A (ja) * | 2006-03-22 | 2009-08-27 | マウント シナイ スクール オブ メディシン | うつ病の治療のためのケタミンの鼻内投与 |
| DE102007009888A1 (de) | 2007-02-28 | 2008-09-04 | Hermann, Holger Lars, Dr. | Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen |
| GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
| MX2014010939A (es) | 2012-03-12 | 2014-11-13 | Janssen Pharmaceutica Nv | Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento. |
| US20140079740A1 (en) | 2012-08-02 | 2014-03-20 | ClinPharm Support GmbH | Oral transmucosal adminstration forms of s-ketamine |
| ES2745024T3 (es) | 2013-03-15 | 2020-02-27 | Janssen Pharmaceutica Nv | Composición farmacéutica de clorhidrato de S-ketamina |
| AU2014240102A1 (en) | 2013-03-15 | 2015-09-17 | Janssen Pharmaceutica Nv | Pharmaceutical composition of S-ketamine hydrochloride |
| US20160338977A1 (en) | 2015-05-20 | 2016-11-24 | Janssen Pharmaceutica Nv | Methods and kits for treating depression |
| PT3505157T (pt) | 2017-12-29 | 2022-02-18 | Celon Pharma Sa | Composição de cetamina em pó seco para administração pulmonar em depressão resistente ao tratamento |
-
2018
- 2018-09-28 EP EP18461615.9A patent/EP3628313A1/en active Pending
-
2019
- 2019-09-24 CA CA3114325A patent/CA3114325A1/en active Pending
- 2019-09-24 BR BR112021005687-4A patent/BR112021005687A2/pt unknown
- 2019-09-24 EP EP19770131.1A patent/EP3856159A1/en active Pending
- 2019-09-24 EA EA202190724A patent/EA202190724A1/ru unknown
- 2019-09-24 MX MX2021003668A patent/MX2021003668A/es unknown
- 2019-09-24 CN CN201980075601.XA patent/CN113038941A/zh active Pending
- 2019-09-24 US US17/281,136 patent/US11925607B2/en active Active
- 2019-09-24 KR KR1020217011554A patent/KR20210068465A/ko unknown
- 2019-09-24 JP JP2021517252A patent/JP7444864B2/ja active Active
- 2019-09-24 AU AU2019349624A patent/AU2019349624A1/en active Pending
- 2019-09-24 WO PCT/EP2019/075735 patent/WO2020064748A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020064748A1 (en) | 2020-04-02 |
| EA202190724A1 (ru) | 2021-08-18 |
| EP3856159A1 (en) | 2021-08-04 |
| JP7444864B2 (ja) | 2024-03-06 |
| BR112021005687A2 (pt) | 2021-06-22 |
| JP2022502429A (ja) | 2022-01-11 |
| EP3628313A1 (en) | 2020-04-01 |
| KR20210068465A (ko) | 2021-06-09 |
| CN113038941A (zh) | 2021-06-25 |
| AU2019349624A1 (en) | 2021-04-29 |
| US11925607B2 (en) | 2024-03-12 |
| US20210353560A1 (en) | 2021-11-18 |
| CA3114325A1 (en) | 2020-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202103404B (en) | Composition and method for treating the lungs | |
| PH12020551425A1 (en) | Rimegepant for cgrp related disorders | |
| EA033113B1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| PH12020550237A1 (en) | Methods for the administration of certain vmat2 inhibitors | |
| NZ726256A (en) | Methods for treating pulmonary non-tuberculous mycobacterial infections | |
| PH12021550302A1 (en) | Methods for the administration of certain vmat2 inhibitors | |
| MX2022003072A (es) | Uso de pridopidina para el tratamiento de la disminucion funcional. | |
| MX2014002171A (es) | Tratamientos de combinacion para hepatitis c. | |
| AU2018264384A1 (en) | Solid forms of berberine ursodeoxycholate and compositions and methods thereof | |
| EA201590933A1 (ru) | Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования | |
| WO2012040228A3 (en) | Aerosol composition for administering drugs | |
| MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
| MX2022000430A (es) | Administracion de agonista de sting e inhibidores de puntos de control. | |
| WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
| MX2021002322A (es) | Nuevos metodos. | |
| MX2020007971A (es) | Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar. | |
| JP2016539122A5 (es) | ||
| JP2016505050A5 (es) | ||
| MX2021003668A (es) | Composición de ketamina para su uso en un método de tratamiento de la depresión por administración pulmonar. | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| MX2017002476A (es) | Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matriz extracelular. | |
| JP2019529569A5 (es) | ||
| MX2021014523A (es) | Metodos para tratar colangiocarcinoma. | |
| IN2014DN09240A (es) |